4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Secretariat of the technology platform for the electricity networks of the future (SmartGrids-ETPS-III)
Date du début: 1 oct. 2012, Date de fin: 30 juin 2016,
The European Technology Platform for Electricity Networks of the Future, also called SmartGrids ETP, began its work in 2005. It aims at fostering cooperation of major stakeholders in these fields through the design, update and implementation of a Strategic Research Agenda. In this context the Platform secretariat seeks to create strong links among stakeholders and R&D and Demonstration initiatives ...
Voir le projet
4
Participants partenaires
TERMINÉ
Planning for energy efficient cities (PLEEC)
Date du début: 1 avr. 2013, Date de fin: 31 mars 2016,
Today climate change causes serious problems to the societies worldwide and Europe starts to feel its consequences. At the same time European community is facing economical problems. One of the main producers of greenhouse gases is the non sustainable energy production and use. Therefore there is an urgent need to reduce energy use in most cost effective way.PLEEC will gather cities with innovativ ...
Voir le projet
18
Participants partenaires
TERMINÉ
ICT services for Electric Vehicle Enhancing the User experience (ICT 4 EVEU)
Date du début: 1 janv. 2012, Date de fin: 31 mars 2015,
ICT 4 EVEU is a project born with the aim of deploying an innovative set of ICT services for electric vehicle (EV) in different and complementary pilots across Europe. The scope of the ICT services is the integration of different management systems operating on the existing EV infrastructures in the cities where the pilots will be run, so that related services are deployed making use of these inte ...
Voir le projet
17
Participants partenaires
TERMINÉ
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis (REGENER-AR)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2014,
Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide with little variation of the prevalence among countries.The current pharmacological management of RA involves early intervention with synthetic disease modifying anti-rheumatic drugs (DMARDs) either singly or in com ...
Voir le projet